 | • レポートコード：QAF27919 • 出版社/出版日：QYResearch / 2021年4月13日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の腫瘍アブレーション市場について種類別（高周波（RF）アブレーション、マイクロ波アブレーション、冷凍アブレーション、その他）、用途別（肝臓がん、肺がん、腎臓がん、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・腫瘍アブレーション市場の概要 ・世界の主要地域別腫瘍アブレーション市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の腫瘍アブレーション市場規模2016-2021：種類別（高周波（RF）アブレーション、マイクロ波アブレーション、冷凍アブレーション、その他） ・世界の腫瘍アブレーション市場予測2012-2027：種類別（高周波（RF）アブレーション、マイクロ波アブレーション、冷凍アブレーション、その他） ・世界の腫瘍アブレーション市場規模2016-2021：用途別（肝臓がん、肺がん、腎臓がん、その他） ・世界の腫瘍アブレーション市場予測2012-2027：用途別（肝臓がん、肺がん、腎臓がん、その他） ・腫瘍アブレーションのアメリカ市場規模と予測2016-2021 ・腫瘍アブレーションのヨーロッパ市場規模と予測2016-2021 ・腫瘍アブレーションの中国市場規模と予測2016-2021 ・腫瘍アブレーションの日本市場規模と予測2016-2021 ・腫瘍アブレーションの東南アジア市場規模と予測2016-2021 ・腫瘍アブレーションのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Angiodynamics、Medtronic、Boston Scientific、Misonix、Sonacare Medical、EDAP TMS、Chongqing Haifu Medical、HealthTronics、J &J） ・腫瘍アブレーションの製造コスト分析 ・販売チャネル、流通業者、顧客 ・腫瘍アブレーションの市場動向・機会・課題 ・調査の結論 |
This is a minimally invasive surgical method to treat solid cancers, Special probes are used to “burn” or “freeze” cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor. This requires only a tiny hole, usually less than 3 mm via which the probe is introduced. When the probe is within the cancer it is attached to a generator which “burns” or “freezes” the cancer.
The classification of Tumor Ablation includes Radiofrequency (RF) Ablation, Microwave Ablation, Cryoablation and others. The proportion of Radiofrequency (RF) Ablation in 2019 is about 65%, and the proportion of Microwave Ablation in 2019 is about 26%.
Tumor Ablation is application in Liver Cancer, Lung Cancer, Kidney Cancer and Other cancers. The most proportion of Tumor Ablation is used in Lung Cancer, and the market share in 2019 is about 20%.
North America is the largest consumption place, with a revenue market share nearly 38% in 2019. Following North America, Europe is the second largest consumption place with the revenue market share of about 28% in 2019.
Market Analysis and Insights: Global Tumor Ablation Market
The global Tumor Ablation market was valued at US$ 533.2 in 2020 and will reach US$ 970.7 million by the end of 2027, growing at a CAGR of 10.5% during 2022-2027.
Global Tumor Ablation Scope and Market Size
The global Tumor Ablation market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tumor Ablation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Radiofrequency (RF) Ablation
Microwave Ablation
Cryoablation
Other Technologies
Segment by Application
Liver Cancer
Lung Cancer
Kidney Cancer
Others
The Tumor Ablation market is analysed and market size information is provided by regions (countries). Segment by Application, the Tumor Ablation market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Angiodynamics
Medtronic
Boston Scientific
Misonix
Sonacare Medical
EDAP TMS
Chongqing Haifu Medical
HealthTronics
J &J
1 Tumor Ablation Market Overview
1.1 Tumor Ablation Product Scope
1.2 Tumor Ablation Segment by Type
1.2.1 Global Tumor Ablation Sales by Type (2016 & 2021 & 2027)
1.2.2 Radiofrequency (RF) Ablation
1.2.3 Microwave Ablation
1.2.4 Cryoablation
1.2.5 Other Technologies
1.3 Tumor Ablation Segment by Application
1.3.1 Global Tumor Ablation Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Liver Cancer
1.3.3 Lung Cancer
1.3.4 Kidney Cancer
1.3.5 Others
1.4 Tumor Ablation Market Estimates and Forecasts (2016-2027)
1.4.1 Global Tumor Ablation Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Tumor Ablation Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Tumor Ablation Price Trends (2016-2027)
2 Tumor Ablation Estimates and Forecasts by Region
2.1 Global Tumor Ablation Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Tumor Ablation Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Tumor Ablation Sales Market Share by Region (2016-2021)
2.2.2 Global Tumor Ablation Revenue Market Share by Region (2016-2021)
2.3 Global Tumor Ablation Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Tumor Ablation Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Tumor Ablation Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Tumor Ablation Estimates and Projections (2016-2027)
2.4.2 Europe Tumor Ablation Estimates and Projections (2016-2027)
2.4.3 China Tumor Ablation Estimates and Projections (2016-2027)
2.4.4 Japan Tumor Ablation Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Tumor Ablation Estimates and Projections (2016-2027)
2.4.6 India Tumor Ablation Estimates and Projections (2016-2027)
3 Global Tumor Ablation Competition Landscape by Players
3.1 Global Top Tumor Ablation Players by Sales (2016-2021)
3.2 Global Top Tumor Ablation Players by Revenue (2016-2021)
3.3 Global Tumor Ablation Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tumor Ablation as of 2020)
3.4 Global Tumor Ablation Average Price by Company (2016-2021)
3.5 Manufacturers Tumor Ablation Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Tumor Ablation Market Size by Type
4.1 Global Tumor Ablation Historic Market Review by Type (2016-2021)
4.1.1 Global Tumor Ablation Sales Market Share by Type (2016-2021)
4.1.2 Global Tumor Ablation Revenue Market Share by Type (2016-2021)
4.1.3 Global Tumor Ablation Price by Type (2016-2021)
4.2 Global Tumor Ablation Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Tumor Ablation Sales Forecast by Type (2022-2027)
4.2.2 Global Tumor Ablation Revenue Forecast by Type (2022-2027)
4.2.3 Global Tumor Ablation Price Forecast by Type (2022-2027)
5 Global Tumor Ablation Market Size by Application
5.1 Global Tumor Ablation Historic Market Review by Application (2016-2021)
5.1.1 Global Tumor Ablation Sales Market Share by Application (2016-2021)
5.1.2 Global Tumor Ablation Revenue Market Share by Application (2016-2021)
5.1.3 Global Tumor Ablation Price by Application (2016-2021)
5.2 Global Tumor Ablation Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Tumor Ablation Sales Forecast by Application (2022-2027)
5.2.2 Global Tumor Ablation Revenue Forecast by Application (2022-2027)
5.2.3 Global Tumor Ablation Price Forecast by Application (2022-2027)
6 North America Tumor Ablation Market Facts & Figures
6.1 North America Tumor Ablation Sales by Company
6.1.1 North America Tumor Ablation Sales by Company (2016-2021)
6.1.2 North America Tumor Ablation Revenue by Company (2016-2021)
6.2 North America Tumor Ablation Sales Breakdown by Type
6.2.1 North America Tumor Ablation Sales Breakdown by Type (2016-2021)
6.2.2 North America Tumor Ablation Sales Breakdown by Type (2022-2027)
6.3 North America Tumor Ablation Sales Breakdown by Application
6.3.1 North America Tumor Ablation Sales Breakdown by Application (2016-2021)
6.3.2 North America Tumor Ablation Sales Breakdown by Application (2022-2027)
7 Europe Tumor Ablation Market Facts & Figures
7.1 Europe Tumor Ablation Sales by Company
7.1.1 Europe Tumor Ablation Sales by Company (2016-2021)
7.1.2 Europe Tumor Ablation Revenue by Company (2016-2021)
7.2 Europe Tumor Ablation Sales Breakdown by Type
7.2.1 Europe Tumor Ablation Sales Breakdown by Type (2016-2021)
7.2.2 Europe Tumor Ablation Sales Breakdown by Type (2022-2027)
7.3 Europe Tumor Ablation Sales Breakdown by Application
7.3.1 Europe 134 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 134 Sales Breakdown by Application (2022-2027)
8 China Tumor Ablation Market Facts & Figures
8.1 China Tumor Ablation Sales by Company
8.1.1 China Tumor Ablation Sales by Company (2016-2021)
8.1.2 China Tumor Ablation Revenue by Company (2016-2021)
8.2 China Tumor Ablation Sales Breakdown by Type
8.2.1 China Tumor Ablation Sales Breakdown by Type (2016-2021)
8.2.2 China Tumor Ablation Sales Breakdown by Type (2022-2027)
8.3 China Tumor Ablation Sales Breakdown by Application
8.3.1 China 242 Sales Breakdown by Application (2016-2021)
8.3.2 China 242 Sales Breakdown by Application (2022-2027)
9 Japan Tumor Ablation Market Facts & Figures
9.1 Japan Tumor Ablation Sales by Company
9.1.1 Japan Tumor Ablation Sales by Company (2016-2021)
9.1.2 Japan Tumor Ablation Revenue by Company (2016-2021)
9.2 Japan Tumor Ablation Sales Breakdown by Type
9.2.1 Japan Tumor Ablation Sales Breakdown by Type (2016-2021)
9.2.2 Japan Tumor Ablation Sales Breakdown by Type (2022-2027)
9.3 Japan Tumor Ablation Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Tumor Ablation Market Facts & Figures
10.1 Southeast Asia Tumor Ablation Sales by Company
10.1.1 Southeast Asia Tumor Ablation Sales by Company (2016-2021)
10.1.2 Southeast Asia Tumor Ablation Revenue by Company (2016-2021)
10.2 Southeast Asia Tumor Ablation Sales Breakdown by Type
10.2.1 Southeast Asia Tumor Ablation Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Tumor Ablation Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Tumor Ablation Sales Breakdown by Application
10.3.1 Southeast Asia Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia Units Sales Breakdown by Application (2022-2027)
11 India Tumor Ablation Market Facts & Figures
11.1 India Tumor Ablation Sales by Company
11.1.1 India Tumor Ablation Sales by Company (2016-2021)
11.1.2 India Tumor Ablation Revenue by Company (2016-2021)
11.2 India Tumor Ablation Sales Breakdown by Type
11.2.1 India Tumor Ablation Sales Breakdown by Type (2016-2021)
11.2.2 India Tumor Ablation Sales Breakdown by Type (2022-2027)
11.3 India Tumor Ablation Sales Breakdown by Application
11.3.1 India Tumor Ablation Sales Breakdown by Application (2016-2021)
11.3.2 India Tumor Ablation Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Tumor Ablation Business
12.1 Angiodynamics
12.1.1 Angiodynamics Corporation Information
12.1.2 Angiodynamics Business Overview
12.1.3 Angiodynamics Tumor Ablation Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Angiodynamics Tumor Ablation Products Offered
12.1.5 Angiodynamics Recent Development
12.2 Medtronic
12.2.1 Medtronic Corporation Information
12.2.2 Medtronic Business Overview
12.2.3 Medtronic Tumor Ablation Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Medtronic Tumor Ablation Products Offered
12.2.5 Medtronic Recent Development
12.3 Boston Scientific
12.3.1 Boston Scientific Corporation Information
12.3.2 Boston Scientific Business Overview
12.3.3 Boston Scientific Tumor Ablation Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Boston Scientific Tumor Ablation Products Offered
12.3.5 Boston Scientific Recent Development
12.4 Misonix
12.4.1 Misonix Corporation Information
12.4.2 Misonix Business Overview
12.4.3 Misonix Tumor Ablation Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Misonix Tumor Ablation Products Offered
12.4.5 Misonix Recent Development
12.5 Sonacare Medical
12.5.1 Sonacare Medical Corporation Information
12.5.2 Sonacare Medical Business Overview
12.5.3 Sonacare Medical Tumor Ablation Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Sonacare Medical Tumor Ablation Products Offered
12.5.5 Sonacare Medical Recent Development
12.6 EDAP TMS
12.6.1 EDAP TMS Corporation Information
12.6.2 EDAP TMS Business Overview
12.6.3 EDAP TMS Tumor Ablation Sales, Revenue and Gross Margin (2016-2021)
12.6.4 EDAP TMS Tumor Ablation Products Offered
12.6.5 EDAP TMS Recent Development
12.7 Chongqing Haifu Medical
12.7.1 Chongqing Haifu Medical Corporation Information
12.7.2 Chongqing Haifu Medical Business Overview
12.7.3 Chongqing Haifu Medical Tumor Ablation Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Chongqing Haifu Medical Tumor Ablation Products Offered
12.7.5 Chongqing Haifu Medical Recent Development
12.8 HealthTronics
12.8.1 HealthTronics Corporation Information
12.8.2 HealthTronics Business Overview
12.8.3 HealthTronics Tumor Ablation Sales, Revenue and Gross Margin (2016-2021)
12.8.4 HealthTronics Tumor Ablation Products Offered
12.8.5 HealthTronics Recent Development
12.9 J &J
12.9.1 J &J Corporation Information
12.9.2 J &J Business Overview
12.9.3 J &J Tumor Ablation Sales, Revenue and Gross Margin (2016-2021)
12.9.4 J &J Tumor Ablation Products Offered
12.9.5 J &J Recent Development
13 Tumor Ablation Manufacturing Cost Analysis
13.1 Tumor Ablation Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Tumor Ablation
13.4 Tumor Ablation Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Tumor Ablation Distributors List
14.3 Tumor Ablation Customers
15 Market Dynamics
15.1 Tumor Ablation Market Trends
15.2 Tumor Ablation Drivers
15.3 Tumor Ablation Market Challenges
15.4 Tumor Ablation Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Tumor Ablation Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Tumor Ablation Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Tumor Ablation Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Tumor Ablation Sales (Units) by Region (2016-2021)
Table 5. Global Tumor Ablation Sales Market Share by Region (2016-2021)
Table 6. Global Tumor Ablation Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Tumor Ablation Revenue Share by Region (2016-2021)
Table 8. Global Tumor Ablation Sales (Units) Forecast by Region (2022-2027)
Table 9. Global Tumor Ablation Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Tumor Ablation Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Tumor Ablation Revenue Share Forecast by Region (2022-2027)
Table 12. Global Tumor Ablation Sales (Units) of Key Companies (2016-2021)
Table 13. Global Tumor Ablation Sales Share by Company (2016-2021)
Table 14. Global Tumor Ablation Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Tumor Ablation Revenue Share by Company (2016-2021)
Table 16. Global Tumor Ablation by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Ablation as of 2020)
Table 17. Global Tumor Ablation Average Price (K USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Tumor Ablation Manufacturing Sites and Area Served
Table 19. Manufacturers Tumor Ablation Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Tumor Ablation Sales (Units) by Type (2016-2021)
Table 22. Global Tumor Ablation Sales Share by Type (2016-2021)
Table 23. Global Tumor Ablation Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Tumor Ablation Price (K USD/Unit) by Type (2016-2021)
Table 25. Global Tumor Ablation Sales Share by Type (2022-2027)
Table 26. Global Tumor Ablation Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Tumor Ablation Revenue Share by Type (2022-2027)
Table 28. Global Tumor Ablation Price (K USD/Unit) by Type (2022-2027)
Table 29. Global Tumor Ablation Sales (Units) by Application (2016-2021)
Table 30. Global Tumor Ablation Sales Share by Application (2016-2021)
Table 31. Global Tumor Ablation Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Tumor Ablation Price (K USD/Unit) by Application (2016-2021)
Table 33. Global Tumor Ablation Sales (Units) by Application (2022-2027)
Table 34. Global Tumor Ablation Sales Share by Application (2022-2027)
Table 35. Global Tumor Ablation Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Tumor Ablation Revenue Share by Application (2022-2027)
Table 37. Global Tumor Ablation Price (K USD/Unit) by Application (2022-2027)
Table 38. North America Tumor Ablation Sales (Units) by Company (2016-2021)
Table 39. North America Tumor Ablation Sales Market Share by Company (2016-2021)
Table 40. North America Tumor Ablation Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Tumor Ablation Revenue Market Share by Company (2016-2021)
Table 42. North America Tumor Ablation Sales by Type (2016-2021) & (Units)
Table 43. North America Tumor Ablation Sales Market Share by Type (2016-2021)
Table 44. North America Tumor Ablation Sales by Type (2022-2027) & (Units)
Table 45. North America Tumor Ablation Sales Market Share by Type (2022-2027)
Table 46. North America Tumor Ablation Sales by Application (2016-2021) & (Units)
Table 47. North America Tumor Ablation Sales Market Share by Application (2016-2021)
Table 48. North America Tumor Ablation Sales by Application (2022-2027) & (Units)
Table 49. North America Tumor Ablation Sales Market Share by Application (2022-2027)
Table 50. Europe Tumor Ablation Sales (Units) by Company (2016-2021)
Table 51. Europe Tumor Ablation Sales Market Share by Company (2016-2021)
Table 52. Europe Tumor Ablation Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Tumor Ablation Revenue Market Share by Company (2016-2021)
Table 54. Europe Tumor Ablation Sales by Type (2016-2021) & (Units)
Table 55. Europe Tumor Ablation Sales Market Share by Type (2016-2021)
Table 56. Europe Tumor Ablation Sales by Type (2022-2027) & (Units)
Table 57. Europe Tumor Ablation Sales Market Share by Type (2022-2027)
Table 58. Europe Tumor Ablation Sales by Application (2016-2021) & (Units)
Table 59. Europe Tumor Ablation Sales Market Share by Application (2016-2021)
Table 60. Europe Tumor Ablation Sales by Application (2022-2027) & (Units)
Table 61. Europe Tumor Ablation Sales Market Share by Application (2022-2027)
Table 62. China Tumor Ablation Sales (Units) by Company (2016-2021)
Table 63. China Tumor Ablation Sales Market Share by Company (2016-2021)
Table 64. China Tumor Ablation Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Tumor Ablation Revenue Market Share by Company (2016-2021)
Table 66. China Tumor Ablation Sales by Type (2016-2021) & (Units)
Table 67. China Tumor Ablation Sales Market Share by Type (2016-2021)
Table 68. China Tumor Ablation Sales by Type (2022-2027) & (Units)
Table 69. China Tumor Ablation Sales Market Share by Type (2022-2027)
Table 70. China Tumor Ablation Sales by Application (2016-2021) & (Units)
Table 71. China Tumor Ablation Sales Market Share by Application (2016-2021)
Table 72. China Tumor Ablation Sales by Application (2022-2027) & (Units)
Table 73. China Tumor Ablation Sales Market Share by Application (2022-2027)
Table 74. Japan Tumor Ablation Sales (Units) by Company (2016-2021)
Table 75. Japan Tumor Ablation Sales Market Share by Company (2016-2021)
Table 76. Japan Tumor Ablation Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Tumor Ablation Revenue Market Share by Company (2016-2021)
Table 78. Japan Tumor Ablation Sales by Type (2016-2021) & (Units)
Table 79. Japan Tumor Ablation Sales Market Share by Type (2016-2021)
Table 80. Japan Tumor Ablation Sales by Type (2022-2027) & (Units)
Table 81. Japan Tumor Ablation Sales Market Share by Type (2022-2027)
Table 82. Japan Tumor Ablation Sales by Application (2016-2021) & (Units)
Table 83. Japan Tumor Ablation Sales Market Share by Application (2016-2021)
Table 84. Japan Tumor Ablation Sales by Application (2022-2027) & (Units)
Table 85. Japan Tumor Ablation Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Tumor Ablation Sales (Units) by Company (2016-2021)
Table 87. Southeast Asia Tumor Ablation Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Tumor Ablation Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Tumor Ablation Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Tumor Ablation Sales by Type (2016-2021) & (Units)
Table 91. Southeast Asia Tumor Ablation Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Tumor Ablation Sales by Type (2022-2027) & (Units)
Table 93. Southeast Asia Tumor Ablation Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Tumor Ablation Sales by Application (2016-2021) & (Units)
Table 95. Southeast Asia Tumor Ablation Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Tumor Ablation Sales by Application (2022-2027) & (Units)
Table 97. Southeast Asia Tumor Ablation Sales Market Share by Application (2022-2027)
Table 98. India Tumor Ablation Sales (Units) by Company (2016-2021)
Table 99. India Tumor Ablation Sales Market Share by Company (2016-2021)
Table 100. India Tumor Ablation Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Tumor Ablation Revenue Market Share by Company (2016-2021)
Table 102. India Tumor Ablation Sales by Type (2016-2021) & (Units)
Table 103. India Tumor Ablation Sales Market Share by Type (2016-2021)
Table 104. India Tumor Ablation Sales by Type (2022-2027) & (Units)
Table 105. India Tumor Ablation Sales Market Share by Type (2022-2027)
Table 106. India Tumor Ablation Sales by Application (2016-2021) & (Units)
Table 107. India Tumor Ablation Sales Market Share by Application (2016-2021)
Table 108. India Tumor Ablation Sales by Application (2022-2027) & (Units)
Table 109. India Tumor Ablation Sales Market Share by Application (2022-2027)
Table 110. Angiodynamics Corporation Information
Table 111. Angiodynamics Description and Business Overview
Table 112. Angiodynamics Tumor Ablation Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 113. Angiodynamics Tumor Ablation Product
Table 114. Angiodynamics Recent Development
Table 115. Medtronic Corporation Information
Table 116. Medtronic Description and Business Overview
Table 117. Medtronic Tumor Ablation Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 118. Medtronic Tumor Ablation Product
Table 119. Medtronic Recent Development
Table 120. Boston Scientific Corporation Information
Table 121. Boston Scientific Description and Business Overview
Table 122. Boston Scientific Tumor Ablation Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 123. Boston Scientific Tumor Ablation Product
Table 124. Boston Scientific Recent Development
Table 125. Misonix Corporation Information
Table 126. Misonix Description and Business Overview
Table 127. Misonix Tumor Ablation Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 128. Misonix Tumor Ablation Product
Table 129. Misonix Recent Development
Table 130. Sonacare Medical Corporation Information
Table 131. Sonacare Medical Description and Business Overview
Table 132. Sonacare Medical Tumor Ablation Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 133. Sonacare Medical Tumor Ablation Product
Table 134. Sonacare Medical Recent Development
Table 135. EDAP TMS Corporation Information
Table 136. EDAP TMS Description and Business Overview
Table 137. EDAP TMS Tumor Ablation Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 138. EDAP TMS Tumor Ablation Product
Table 139. EDAP TMS Recent Development
Table 140. Chongqing Haifu Medical Corporation Information
Table 141. Chongqing Haifu Medical Description and Business Overview
Table 142. Chongqing Haifu Medical Tumor Ablation Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 143. Chongqing Haifu Medical Tumor Ablation Product
Table 144. Chongqing Haifu Medical Recent Development
Table 145. HealthTronics Corporation Information
Table 146. HealthTronics Tumor Ablation Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 147. HealthTronics Description and Business Overview
Table 148. HealthTronics Tumor Ablation Product
Table 149. HealthTronics Recent Development
Table 150. J &J Corporation Information
Table 151. J &J Tumor Ablation Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 152. J &J Description and Business Overview
Table 153. J &J Tumor Ablation Product
Table 154. J &J Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Tumor Ablation Distributors List
Table 158. Tumor Ablation Customers List
Table 159. Tumor Ablation Market Trends
Table 160. Tumor Ablation Market Drivers
Table 161. Tumor Ablation Market Challenges
Table 162. Tumor Ablation Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Tumor Ablation Product Picture
Figure 2. Global Tumor Ablation Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Tumor Ablation Sales Market Share by Application in 2021 & 2027
Figure 6. Liver Cancer Examples
Figure 7. Lung Cancer Examples
Figure 8. Kidney Cancer Examples
Figure 9. Others Examples
Figure 10. Global Tumor Ablation Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Tumor Ablation Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Tumor Ablation Sales (Units) Growth Rate (2016-2027)
Figure 13. Global Tumor Ablation Price Trends Growth Rate (2016-2027) (K USD/Unit)
Figure 14. Global Tumor Ablation Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Tumor Ablation Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Tumor Ablation Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Tumor Ablation Sales (Units) Growth Rate (2016-2027)
Figure 18. Europe Tumor Ablation Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Tumor Ablation Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Tumor Ablation Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Tumor Ablation Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Tumor Ablation Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Tumor Ablation Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Tumor Ablation Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Tumor Ablation Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Tumor Ablation Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Tumor Ablation Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Tumor Ablation Players Market Share by Revenue in Tumor Ablation: 2016 & 2020
Figure 29. Tumor Ablation Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Tumor Ablation Revenue Share by Type (2016-2021)
Figure 31. Global Tumor Ablation Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Tumor Ablation Revenue Share by Application (2016-2021)
Figure 33. Global Tumor Ablation Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Tumor Ablation Sales Market Share by Type in 2020
Figure 35. North America Tumor Ablation Sales Market Share by Application in 2020
Figure 36. Europe Tumor Ablation Sales Market Share by Type in 2020
Figure 37. Europe Tumor Ablation Sales Market Share by Application in 2020
Figure 38. China Tumor Ablation Sales Market Share by Type in 2020
Figure 39. China Tumor Ablation Sales Market Share by Application in 2020
Figure 40. Japan Tumor Ablation Sales Market Share by Type in 2020
Figure 41. Japan Tumor Ablation Sales Market Share by Application in 2020
Figure 42. Southeast Asia Tumor Ablation Sales Market Share by Type in 2020
Figure 43. Southeast Asia Tumor Ablation Sales Market Share by Application in 2020
Figure 44. India Tumor Ablation Sales Market Share by Type in 2020
Figure 45. India Tumor Ablation Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Tumor Ablation
Figure 48. Manufacturing Process Analysis of Tumor Ablation
Figure 49. Tumor Ablation Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
世界の腫瘍ラジオ波焼灼療法市場規模・現状・予測（2021年-2027年） Radiofrequency ablation (or RFA) is a procedure used to reduce pain. An electrical current produced by a radio wave is used to heat up a small area of nerve tissue, thereby decreasing pain signals from that specific area. Market Analysis and Insights: Global Tumor Radiofrequency Ablation Market The …- 腫瘍高周波アブレーションのグローバル市場：規模・現状・予測2019-2025 Radiofrequency ablation (or RFA) is a procedure used to reduce pain. An electrical current produced by a radio wave is used to heat up a small area of nerve tissue, thereby decreasing pain signals from that specific area.In 2018, the global Tumor Radiofrequency Ablation market size was xx million US…
- 腫瘍高周波アブレーションのグローバル市場：規模・現状・予測2019-2025 Radiofrequency ablation (or RFA) is a procedure used to reduce pain. An electrical current produced by a radio wave is used to heat up a small area of nerve tissue, thereby decreasing pain signals from that specific area.In 2018, the global Tumor Radiofrequency Ablation market size was xx million US…
- 世界の外科的腫瘍切除市場規模・現状・予測（2021年-2027年） Surgical Tumor Ablation is a minimally invasive technique that is commonly used in the treatment of tumors of the liver, kidney, bone, and lung. It is an important option for people who have failed chemotherapy or radiotherapy or are not surgical candidates. Market Analysis and Insights: Global Surg…
- 世界の腫瘍マイクロ波アブレーションシステム市場規模・現状・予測（2021年-2027年） Microwave Ablation Systems is an emerging tissue ablation technique utilized to treat large, small tumors, and inoperable tumors. The technique uses numerous antennae to achieve microwave ablation in a small targeted area to prevent healthy tissue damage. This ablation technique is widely employed t…